期刊文献+

强力霉素对心肌间质缺血再灌注损伤影响的研究 被引量:1

Effect of doxycycline on cardial interstitium with ischemic reperfusion injury
下载PDF
导出
摘要 目的 :探讨不同浓度的强力霉素对离体鼠心缺血再灌注心肌间质损伤的影响。方法 :Sprague Dawley(SD)大鼠 40只 ,随机分为对照组、缺血再灌注组和强力霉素 1、2、3组 ,每组 8只。分别建立改良的Langendorrf离体心灌注模型 ,测定左室收缩峰压及其压力微分 ,氯胺T法测定心肌胶原含量 ,免疫组化法测定Ⅰ /Ⅲ胶原比例 ,酶谱法检测心肌基质金属蛋白酶 2 (MMP 2 )的表达 ,电镜观察心肌超微结构。结果 :强力霉素对离体心缺血再灌注后心肌间质损伤 ,以及心功能有明显的保护作用 ,且与浓度有关。其保护作用与抑制MMP 2的表达有关。结论 :强力霉素对离体鼠心缺血再灌注后心肌间质损伤有与浓度相关的保护作用。 Objective To assess the effect of different concentration doxycycline on cardial interstitium with ischemic reperfusion (I/R) injury in isolated rat heart. Methods 40 SD rats were randomly divided into five groups: control group (C), ischemic reperfusion group(I/R) and doxycyline 1 group(D1), doxycyline 2 group(D2), doxycyline 3 group(D3) . Each group includes 8 rats. To establish isolated rat heart modified langendorff model retrograde perfusion. The left ventricular peak systolic pressure and its derivate (±dp/dt) were observed. The activity of MMP 2 of myocardium was measured by zymography and callagen amount by the method of chloramines T, and the ratio of Ⅰ/Ⅲ collagen was assessed by immunohistochemical stain. The microstructure of myocardium was observed with electron microscope. Results Doxycycline has protective effect on cardiac interstitial injury with I/R and cardiac function recovery, and there was a concentration dependent increase in the protective effect. Conclusion Doxycycline has concentration dependent protective effect on cardiac interstitial injury with I/R.
出处 《实用医学杂志》 CAS 2004年第3期255-257,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献14

  • 1杜昕.肾素-血管紧张素-醛固酮系统与心肌间质纤维化[J].临床心血管病杂志,1999,15(12):575-576. 被引量:6
  • 2Sawicki G, Salas E, Murat J, et al. Release of gelatinase A during platelet activation mediates ago-egation. Nature, 1997, 386(6625): 616-619.
  • 3Sawicki G, Sanders EJ, Salas E, et al. Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost. 1998,80(5): 836- 839.
  • 4Masure S, Paemen L, van Aelst 1,et al. Production and characterization of recombinant active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration. Eur J Biochem, 1997, 244(1): 21-30.
  • 5Cheung PY, Sawicki G, Wozniak M, et al. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart.Circulation.2000, 101(15):1833-1839.
  • 6Golub LM, Lee HM, Ryan ME, et al. Tetracyclines inhibit connective tissue breakdowm by multiple non-antimicrobial mechanisms. Adv Dent Res.1998,12(2):12-26
  • 7Ryan ME, Ramamurthy S, Golub LM. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr Opin Periodontol, 1996,3:85-96.
  • 8Cho A, Reidy MA. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res, 2002, 91(9): 845-851.
  • 9Seflor RE, Seftor EA, De Laco JE, et al. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin Exp Metastasis, 1998, 16(3) :217 - 225.
  • 10Smith GN Jr, Brandt KD, Hasty KA. Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity. Arthritis Rheum,1996, 39(2):235-244.

二级参考文献2

  • 1Brilla C G,Am J Cardiol,1995年,76卷,8D页
  • 2Brilla C G,J Mol Cell Cardiol,1994年,26卷,809页

共引文献5

同被引文献22

  • 1王绍欣,董平栓,杨旭明,杨喜山,李转珍,汪砚雨,李志娟,尚喜艳.急性心肌梗死患者PCI术前后血清基质金属蛋白酶水平的变化及临床意义[J].中原医刊,2006,33(15):24-25. 被引量:1
  • 2Lmcdonough J,Arrell K,Van Eyk JE.Troponin I degradation and covalent complex formation accompanied myocardialischemia Preperfusion injury[J].Circ Res,1999,84:9-20.
  • 3Feldman LJ,Mazighi M,Scheuble A,et al.Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercho lesterolemic rabbit[J].Circulation,2001.103(25):117-122.
  • 4Lalu MM,Pasini E,Schulze CJ,et al.Ischaemiareperfusion injury activatesmatrixmetallop roteinases in the hum an heart[J].Eur Heart J,2005,26(1):27-35.
  • 5Lindsey M,Wedin K,Brown MD.et al.Matrixdependent mechanism of neutrophil mediated release and activation of matrix metalloproteinase 29 in myocardialischemia preperfusion[J].Circulation,1998,97:1 707-1 715.
  • 6Kaden Plasma JJ,Dempfle CE,Sueselbeck T,et al.Time-dependent changes in the concentration of matrix metalloproteinase 9 after acute cardial infarction[J].Cardiology,2003,99(3):140-144.
  • 7Etoh T,Joffs C.Deschamps AM,et al.Myocardial and interstitial matrix metallop roteinase activity after acute myocardial infarction in pigs[J].Am J Physiol Heart Circ Physiol,2001,281(3):987-994.
  • 8Tao ZY,Cavasin MA,Yang F,et al.Temporal changes in matrixmetallop roteinase exp reasion and inflammatoryy response associated with cardiacrup ture after myocardial infarction in mice[J].Life Sci,2004,74(12):1 561-1 572.
  • 9Romanic AM,Harrison SM,Bao W,et al.Myocardial protection from ischemia reperfusion injury by targeted deletion ofmatrixmetallop roteinase-9[J].Cariovasc Res,2002,54(3):495-498.
  • 10Strieter RM,Koch AE,Antony VB,et al.The immunopathology of chemotactic cytokines:the role of interleukin-8 and monocyte chemoattractant protein-1[J].J Lab Clin Med,1994,123(2):183-197.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部